GSK says Moncef Slaoui dismissed as Galvani chairman By Reuters

FRANKFURT (Reuters) – Glaxosmithkline (LON:GSK) said that Moncef Slaoui has been dismissed as chairman of Galvani Bioelectronics, which is majority owned by GSK.

GSK said the termination of Slaoui’s contract was with immediate effect. Slaoui was not immediately available for comment.